Wells Fargo raises Merck price target to $170 from $150
Wells Fargo raised its Merck price target to $170.00 per share from $150.00 and maintained its Overweight rating, per TradingView News / Benzinga ratings actions.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.